983 related articles for article (PubMed ID: 26720853)
41. Effect of cost sharing on prescription drug use by Medicare beneficiaries prior to the Medicare Drug Benefit and potential adverse selection in the benefit.
Goedken AM; Urmie JM; Farris KB; Doucette WR
J Am Pharm Assoc (2003); 2009; 49(1):18-25. PubMed ID: 19196592
[TBL] [Abstract][Full Text] [Related]
42. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
Lillard LA; Rogowski J; Kington R
Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
[TBL] [Abstract][Full Text] [Related]
43. Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015.
Watanabe JH; Chau DL; Hirsch JD
J Am Geriatr Soc; 2018 Aug; 66(8):1621-1624. PubMed ID: 29972589
[TBL] [Abstract][Full Text] [Related]
44. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
[TBL] [Abstract][Full Text] [Related]
45. Geographic variation in medication adherence in commercial and Medicare part D populations.
Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
[TBL] [Abstract][Full Text] [Related]
46. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
[TBL] [Abstract][Full Text] [Related]
47. Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma.
Prager AJ; Liebmann JM; Cioffi GA; Blumberg DM
JAMA Ophthalmol; 2016 Apr; 134(4):357-65. PubMed ID: 26747060
[TBL] [Abstract][Full Text] [Related]
48. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.
Odouard IC; Anderson GF; Alexander GC; Ballreich J
J Manag Care Spec Pharm; 2024 Mar; 30(3):269-278. PubMed ID: 38140901
[TBL] [Abstract][Full Text] [Related]
49. The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities.
Nelson RE; Nelson SL; Huttner B; Gundlapalli A
Disabil Health J; 2014 Jan; 7(1):64-9. PubMed ID: 24411509
[TBL] [Abstract][Full Text] [Related]
50. Prescription drug spending and hospital use among Medicare beneficiaries with heart failure.
McGee BT; Higgins MK; Phillips V; Butler J
Res Social Adm Pharm; 2020 Oct; 16(10):1452-1458. PubMed ID: 31953113
[TBL] [Abstract][Full Text] [Related]
51. Coverage for hepatitis C drugs in Medicare Part D.
Jung JK; Feldman R; Cheong C; Du P; Leslie D
Am J Manag Care; 2016 May; 22(6 Spec No.):SP220-6. PubMed ID: 27266952
[TBL] [Abstract][Full Text] [Related]
52. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
[TBL] [Abstract][Full Text] [Related]
53. Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage Phase.
Trish E; Xu J; Joyce G
Health Aff (Millwood); 2016 Sep; 35(9):1564-71. PubMed ID: 27605634
[TBL] [Abstract][Full Text] [Related]
54. Medicare part D after 2 years.
Joyce GF; Goldman DP; Vogt WB; Sun E; Jena AB
Am J Manag Care; 2009 Aug; 15(8):536-44. PubMed ID: 19670957
[TBL] [Abstract][Full Text] [Related]
55. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
Tseng CW; Brook RH; Keeler E; Mangione CM
JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
[TBL] [Abstract][Full Text] [Related]
56. Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket Cap.
Trish E; Xu J; Joyce G
Health Aff (Millwood); 2018 Jul; 37(7):1048-1056. PubMed ID: 29985706
[TBL] [Abstract][Full Text] [Related]
57. Prescription Drug Spending and Medication Adherence Among Medicare Beneficiaries with Heart Failure.
McGee BT; Phillips V; Higgins MK; Butler J
J Manag Care Spec Pharm; 2019 Jun; 25(6):705-713. PubMed ID: 31134861
[TBL] [Abstract][Full Text] [Related]
58. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
Sengupta S
N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
[TBL] [Abstract][Full Text] [Related]
59. Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.
Alexander GC; Schiman C; Kaestner R
Med Care Res Rev; 2018 Apr; 75(2):153-174. PubMed ID: 29148319
[TBL] [Abstract][Full Text] [Related]
60. The role of satisfaction and switching costs in Medicare Part D choices.
Han J; Ko DW; Urmie JM
Res Social Adm Pharm; 2014; 10(2):398-407. PubMed ID: 23988694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]